Abstract:Objective To investigate the application value of susceptibility weighted imaging (SWI) combined with platelet distribution width (PDW) in intravenous thrombolysis for treatment of patients with acute cerebral infarction (ACI). Methods One hundred and ten patients with ACI treated by intravenous thrombolysis admitted to the Department of Radiology of the Second Affiliated Hospital of Medical College of Zhejiang University from February 2017 to June 2018 were enrolled as the subjects. Before treatment, all patients were detected by routine magnetic resonance imaging (MRI), SWI scanning and PDW detection. The patients were divided into hemorrhage group (77 cases) and non-hemorrhage group (33 cases) according to the presence or absence of hemorrhage shown in SWI, and according to the amount of bleeding, the hemorrhage group patients were subdivided into light (24 cases), medium (32 cases) and severe (21 cases) three groups. After intravenous thrombolysis, the patients were scanned by SWI to show whether bleeding being present or not, the cerebral microbleeding (CMBs) after 24 hours treatment in two groups, and after treatment of 14 days, modified Rankin score (MRS), PDW and hemorrhagic transformation (HT) situation in the two groups were evaluated and compared, the differences in hemorrhagic infarction 1 (HI1), hemorrhagic infarction 2 (HI2), parenchymal hemorrhage 1 (PH1) and parenchymal hemorrhage 2 (PH2) in different bleeding volume groups were compared. Results Before treatment, 129 lesions detected by SWI were significantly greater than 14 lesions detected by T1 weighted imaging, 22 lesions detected by T2 weighted imaging and 86 lesions detected by diffusion weighted imaging. After treatment for 24 hours, the number of CMBs (number: 10 vs. 0), after treatment for 14 days, the incidence of HT [36.36% (28/77) vs. 12.12% (4/33)], MRS (1.78±0.39 vs. 1.51±0.42) and PDW [(12.34±5.29)% vs. (6.79±3.27)%] in the hemorrhagic group were higher than those in non-hemorrhagic group (all P < 0.05). After treatment of 14 days, the incidences of HT [71.43% (15/21) vs. 20.83% (5/24), 25.00% (8/32)], PDW [(14.52±4.11)% vs. (10.78±3.67)%, (11.34±3.89)%] in severe group were higher than those in light group and moderate groups (all P < 0.05), and the rate of good prognosis was significantly lower than those in mild and moderate groups [42.86% (9/21) vs. 70.83% (17/24), 71.88% (23/32), P < 0.05]. The incidence of HT in severe group was also significantly higher than those in the non-hemorrhage group [71.43% (15/21) vs. 11.76% (4/34), P < 0.05]. Conclusion SWI combined with PDW can guide the intravenous thrombolysis very well for patients with ACI, and has relatively high clinical value.

Comparison of the therapeutic effect between interventional treatment and anticoagulation therapy alone in patients with intracranial venous sinus thrombosis

Clinical study of cerebral infarction prevention with warfarin in nonvalvular atrial fibrillation

A study on application value of susceptibility weighted imaging combined with platelet distribution width in intravenous thrombolysis for treatment of patients with acute cerebral infarction

Balloon-Assisted Thrombectomy and Intrasinus Urokinase Thrombolysis for Severe Cerebral Venous Sinus Thrombosis

Combined intraarterial and intravenous thrombolysis for severe cerebral venous sinus thrombosis

Safety and Efficacy of Intravascular Ultrasound As an Adjunct to Stenting for Cerebral Venous Sinus Stenosis-Induced Idiopathic Intracranial Hypertension: a Pilot Study

Individualized Endovascular Treatment of Intracranial Vein Sinous Thrombosis Based on the Stage of Disease

Advances in the Clinical Diagnosis and Treatment of Intracranial Venous Sinus Thrombosis

Analysis of the Safety and Effectiveness of Mechanical Thrombectomy in the Treatment of Cerebral Venous Sinus Thrombosis

Effects of low molecular weight heparin combined with hyperbaric oxygen on neurologic function and coagulation factors in patients with intracranial venous thrombosis

Analysis of Curative Effect and Prognosis of Intracranial Vascular Interventional Therapy for Ischemic Cerebrovascular Disease

A modified thrombolytic scheme for the treatment of cerebral venous sinus thrombosis

Endovascular Therapy of Serious Cerebral Venous Sinus Thrombosis

Efficacy and safety of direct oral anticoagulants versus warfarin in the treatment of cerebral venous sinus thrombosis

A comparative study of intra-arterial thrombolysis combined with mechanical adjuvant in the treatment of ischemic stroke patients with acute large artery occlusion in either anterior circulation or posterior circulation

The strategy in the treatment of cerebral venous sinus thrombosis

Meta-Analysis of the Effectiveness and Safety of Intravenous Thrombolysis in Patients with Acute Cerebral Infarction

Effective evaluation of combined treatment in delayed cerebrovascular spasm after subarachnoid hemorrhage

Clinical therapeutic effect of sequential anti-coagulation therapy for ischemic cerebral vascular disease

[Individualized Endovascular Treatment of Cerebral Venous Thrombosis: Analysis of 168 Patients].

Comparison of the efficacy and safety between intravenous thrombolysis, direct endovascular therapy, and bridging therapy for acute basilar artery occlusion in cerebral infarction patients